06:59 EDT Bristol Myers (BMY) to acquire Orbital Therapeutics for $1.5B in cash at closing
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers Squibb call volume above normal and directionally bullish
- GoodRx, others in talks with White House to join TrumpRx, Reuters reports
- Trump Trade: Generics to be excluded from pharma tariff plan
- Generics to be excluded from Trump’s pharma tariff plan, WSJ reports
- Hold Rating Issued for Bristol-Myers Squibb Amid Declining Cobenfy Prescriptions and Revenue Forecast Miss